Figure 3.
Study outcomes regarding patient prognosis. The comparison of all-cause mortality (A), cardiovascular mortality (B), and heart failure hospitalization (C) between ATTRwt-CM patients with AF/AFL/AT who underwent catheter ablation (blue), ATTRwt-CM patients with AF/AFL/AT who did not underwent catheter ablation (red), and ATTRwt-CM patients without AF/AFL/AT (green) was shown. AF, atrial fibrillation; AFL, atrial flutter; AT, atrial tachycardia; ATTRwt-CM, wild-type transthyretin amyloid cardiomyopathy; HR, hazard ratio.
